herbal medicine

BioResearch Open Gain access to explores Cell-SELEX technology SELEX is an instant.

BioResearch Open Gain access to explores Cell-SELEX technology SELEX is an instant, efficient, and iterative high-throughput way for screening large libraries of molecules to recognize people that have the potential to end up being developed as drug substances or research tools. Improvements in SELEX technology which have allowed screening in live cells, called Cell-SELEX, are explored in a thorough Review content published in BioResearch Open up Gain access to, a bimonthly peer-examined open gain access to journal from Mary Ann Liebert, Inc. This article is available free of charge on the BioResearch Open up Gain access to website. Continue reading

BioSante announces demonstration of LibiGel safety upgrade at ENDO 2010 BioSante Pharmaceuticals comment ça marche.

BioSante announces demonstration of LibiGel safety upgrade at ENDO 2010 BioSante Pharmaceuticals, Inc. , will show a LibiGel safety revise at the 2010 Annual Getting together with of the Endocrine Culture , being kept from June 19-22, 2010 in NORTH PARK, California. Snabes, MD, PhD, BioSante’s vice president of clinical development, gives a demonstration entitled, ‘Low Cardiovascular Event Price in Post-menopausal Females with an increase of Cardiac Risk: Results from the Ongoing Blinded LibiGel Cardiovascular and Breast Cancer Security Study,on Sunday June 20 ‘, 2010 comment ça marche . The update includes the full total results of the 3rd unblinded overview of safety data, including 1,500 women-years of exposure, by the independent Data Monitoring Committee of the LibiGel Cardiovascular and Breasts Cancer Safety Study. Continue reading